• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Allogeneic T-cells are phagocytosed by XCR1+DCs and induce donor antibody production.

Research Project

Project/Area Number 16K08474
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field General anatomy (including histology/embryology)
Research InstitutionDokkyo Medical University

Principal Investigator

Kitazawa Yusuke  獨協医科大学, 医学部, 助教 (00467581)

Project Period (FY) 2016-04-01 – 2020-03-31
Project Status Completed (Fiscal Year 2019)
Budget Amount *help
¥4,810,000 (Direct Cost: ¥3,700,000、Indirect Cost: ¥1,110,000)
Fiscal Year 2018: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2017: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2016: ¥2,340,000 (Direct Cost: ¥1,800,000、Indirect Cost: ¥540,000)
KeywordsアロT細胞 / ワクチンベクター / アロ抗体産細胞応答 / 脾臓 / XCR1陽性DC / DST / ハプテン抗原 / FITC抗原 / アロ抗体産生応答 / 免疫組織染色 / XCR1 / FITC / ドナー特異的輸血 / ドナー特異的抗体 / 抗体産生応答 / 細胞増殖 / サイミジンアナログ / フェノタイプ解析 / 細胞間相互作用 / 多重免疫染色 / 免疫学 / 細胞・組織 / DST(ドナー血輸血) / チミジンアナログ
Outline of Final Research Achievements

Donor-specific blood transfusion (DST) is one of the tolerance-inducing protocols used in not only experimental but also clinical transplantation, but detailed mechanism is unknown. The first, we demonstrated that a single DST efficiently induces a anti-donor class I MHC (MHCI) antibody-forming cell and donor-specific regulatory T cell responses, mainly in the spleen. Therefore, in this study, we examined primarily focused on a nature of these antibodies and a mechanism for this efficient alloresponse in rats. The result, we found the T-cells in the blood transfusion can alloresponse most efficiently in the spleen PALS. In spleen, after killed donor T-cell by NK cells, XCR1+ resident dendritic cells phagocytosed donor MHCI + fragments, induced AFC-response. In addition, Hapten-antigen labeled donor T-cell induced AFC-response and produced anti-FITC antibody. The conclusion, Allogeneic T-cells may be clinically applicable as vaccine vectors for prophylactic antibody production even.

Academic Significance and Societal Importance of the Research Achievements

研究代表者は、輸血液中のドナーT 細胞がドナー特異的輸血(DST) のアロ抗体産生応答(AFC 応答)を最も効率的に誘導することを突き止め、その誘導メカニズムを明らかにした。さらにハプテン抗原を結合させたドナーT 細胞の移入実験によって、脾臓で抗ハプテンAFC 応答が起こることを証明した。これによりウイルスや腫瘍のペプチドをT 細胞に結合させて、効率よく抗ペプチド 抗体を作らせるという全く新しいワクチン構想の提案に繋がるという意義がある。

Report

(5 results)
  • 2019 Annual Research Report   Final Research Report ( PDF )
  • 2018 Research-status Report
  • 2017 Research-status Report
  • 2016 Research-status Report
  • Research Products

    (4 results)

All 2019 2018

All Journal Article (2 results) (of which Peer Reviewed: 2 results,  Open Access: 2 results) Presentation (1 results) Patent(Industrial Property Rights) (1 results)

  • [Journal Article] Novel Targeting to XCR1+ Dendritic Cells Using Allogeneic T Cells for Polytopical Antibody Responses in the Lymph Nodes2019

    • Author(s)
      Kitazawa Yusuke、Ueta Hisashi、Sawanobori Yasushi、Katakai Tomoya、Yoneyama Hiroyuki、Ueha Satoshi、Matsushima Kouji、Tokuda Nobuko、Matsuno Kenjiro
    • Journal Title

      Frontiers in Immunology

      Volume: 10 Pages: 1195-1195

    • DOI

      10.3389/fimmu.2019.01195

    • Related Report
      2019 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Single blood transfusion induces the production of donor-specific alloantibodies and regulatory T cells mainly in the spleen.2018

    • Author(s)
      Ueta H, Kitazawa Y, Sawanobori Y, Ueno T, Ueha S, Matsushima K, Matsuno K.
    • Journal Title

      Int Immunol

      Volume: 30 Issue: 2 Pages: 53-67

    • DOI

      10.1093/intimm/dxx078

    • Related Report
      2018 Research-status Report 2017 Research-status Report
    • Peer Reviewed / Open Access
  • [Presentation] ドナーT細胞のXCR1+樹状細胞による抗体産生応答2019

    • Author(s)
      北沢祐介
    • Organizer
      日本解剖学会
    • Related Report
      2018 Research-status Report
  • [Patent(Industrial Property Rights)] T細胞ワクチン2019

    • Inventor(s)
      松野健二郎、上田祐司、北沢祐介
    • Industrial Property Rights Holder
      獨協医科大学
    • Industrial Property Rights Type
      特許
    • Filing Date
      2019
    • Acquisition Date
      2019
    • Related Report
      2018 Research-status Report

URL: 

Published: 2016-04-21   Modified: 2021-02-19  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi